QNRX
Quoin Pharmaceuticals Ltd.
+0.12 (+1.74%)7.02USD12.4K成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 ·
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。外國發行人(20-F)通常只申報半年或年度,逐季會有缺。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.6M | 3.4M | 3.1M | 2.3M | 2.1M | 2.4M | 1.1M | 588K | 885K | 832K | 759K | 625K |
| 銷售管理費用 | 1.8M | 1.7M | 1.4M | 1.7M | 1.7M | 1.6M | 1.4M | 1.5M | 1.6M | 1.4M | 1.4M | 1.6M |
| 營業利益 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −5.4M+45% | −5.0M+31% | −4.3M+85% | −3.9M+100% | −3.7M+59% | −3.8M+85% | −2.3M+22% | −2.0M-6% | −2.3M | −2.1M | −1.9M | −2.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋股數 | – | – | – | – | – | – | – | – | – | – | – | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 3.8M | 3.1M | 3.8M | 1.8M | 1.7M | 3.8M | 3.1M | 2.8M | 1.8M | 2.4M | 3.2M | 4.8M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 12.0M | 15.7M | 20.4M | 6.4M | 8.9M | 13.0M | 11.4M | 14.1M | 16.1M | 12.2M | 15.1M | 16.7M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 8.0M | 6.9M | 7.3M | 7.6M | 6.4M | 7.0M | 5.9M | 6.6M | 7.0M | 6.5M | 7.7M | 7.6M |
| 股東權益 | 3.9M | 8.8M | 13.1M | −1.2M | 2.6M | 5.9M | 5.4M | 7.5M | 9.1M | 5.7M | 7.4M | 9.1M |
| 負債比 | 67.1% | 44.1% | 35.7% | 118.9% | 71.4% | 54.3% | 52.2% | 46.8% | 43.4% | 53.5% | 50.8% | 45.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.9M+88% | – | – | – | −2.6M | – | – | −1.4M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −15.8M | –% | – | – |
| FY2024 | – | – | −9.0M | –% | – | – |
| FY2023 | – | – | −8.7M | –% | – | – |
| FY2022 | – | – | −9.4M | –% | – | – |
| FY2021 | 0.00 | – | −21.5M | –% | -0.01 | – |
| FY2020 | 0.00 | – | −2.1M | –% | -0.70 | – |
| FY2019 | 0.00 | – | −1.6M | –% | -0.52 | – |